Compounds > 6-deoxy-6-fluorogalactose

Page last updated: 2024-12-08

6-deoxy-6-fluorogalactose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-deoxy-6-fluorogalactose: RN given refers to (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	165242
SCHEMBL ID	3169723
MeSH ID	M0113060

Synonyms (12)

Synonym
4536-07-6
(2r,3s,4r,5s)-6-fluoro-2,3,4,5-tetrahydroxyhexanal
6-(18f)fluoro-l-fucose
d-galactose, 6-deoxy-6-fluoro-
6-(18f)ffuc
6-deoxy-6-fluorogalactose
6-fluoro-6-deoxy-d-galactose
SCHEMBL3169723
W-202789
AKOS027381774
DTXSID10963374
6-deoxy-6-fluorohexose

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2 (28.57)	18.7374
1990's	4 (57.14)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.32 (24.57)
Research Supply Index	2.08 (2.92)
Research Growth Index	4.40 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.32)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	7 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
thymidine [no description available]	1.98	1	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
floxuridine Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.. floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.	1.98	1	0	nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent
galactose galactopyranose : The pyranose form of galactose.	2.66	3	0	D-galactose; galactopyranose	Escherichia coli metabolite; mouse metabolite
methionine Methionine: A sulfur-containing essential L-amino acid that is important in many body functions.. methionine : A sulfur-containing amino acid that is butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4.	1.98	1	0	aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid	antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical
fucose Fucose: A six-member ring deoxysugar with the chemical formula C6H12O5. It lacks a hydroxyl group on the carbon at position 6 of the molecule.. L-fucopyranose : The pyranose form of L-fucose.. fucose : Any deoxygalactose that is deoxygenated at the 6-position.	3.36	7	0	fucopyranose; L-fucose	Escherichia coli metabolite; mouse metabolite
galactose aldohexose : A hexose with a (potential) aldehyde group at one end.	2.05	1	0
methionine methyl ester [no description available]	1.98	1	0
methylthymidine methylthymidine: RN given refers to N-3-methylthymidine	1.98	1	0
fluorodeoxyglucose f18 Fluorodeoxyglucose F18: The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)	1.98	1	0	2-deoxy-2-((18)F)fluoro-D-glucose; 2-deoxy-2-fluoro-aldehydo-D-glucose
deoxyglucose Deoxyglucose: 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.. deoxyglucose : A deoxyhexose comprising glucose having at least one hydroxy group replaced by hydrogen.	1.98	1	0
2-deoxy-lyxo-hexose 2-deoxy-lyxo-hexose: RN given refers to cpd without isomeric designation	1.98	1	0
2-deoxy-2-fluorogalactose 2-deoxy-2-fluorogalactose: structure given in first source; used as a tracer for evaluation of liver function by PET	1.98	1	0
idopyranose L-idose : The L-stereoisomer of idose.. L-idopyranose : The pyranose form of L-idose.	2.05	1	0	L-idose

Condition	Indicated	Relationship Strength	Studies	Trials
Leukemia L 1210 [description not available]	0	1.96	1	0
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	0	1.98	1	0
Cancer of Lung [description not available]	0	1.98	1	0
Metastase [description not available]	0	1.98	1	0
Experimental Neoplasms [description not available]	0	2.89	4	0
Lung Neoplasms Tumors or cancer of the LUNG.	0	1.98	1	0
Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	0	1.98	1	0